Q2 EPS Estimates for Fabrinet Raised by Northland Securities

Fabrinet (NYSE:FN) – Stock analysts at Northland Securities boosted their Q2 2027 earnings estimates for Fabrinet in a research report issued on Tuesday, August 18th. Northland Securities analyst T. Savageaux now forecasts that the technology company will post earnings of $4.21 per share for the quarter, up from their prior forecast of $4.18. The consensus estimate for Fabrinet’s current full-year earnings is $16.46 per share. Northland Securities also issued estimates for Fabrinet’s Q3 2027 earnings at $4.60 EPS and Q4 2027 earnings at $4.94 EPS.

Fabrinet (NYSE:FN) last issued its earnings results on Monday, August 17th. The technology company reported $4.10 earnings per share for the quarter, topping analysts’ consensus estimates of $3.81 by $0.29. The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.28 billion. Fabrinet had a net margin of 10.19% and a return on equity of 21.23%. The firm’s revenue was up 44.6% compared to the same quarter last year. During the same period in the prior year, the company earned $2.65 earnings per share. Fabrinet has set its Q1 2027 guidance at 4.100-4.250 EPS.

FN has been the topic of a number of other research reports. Fox Advisors raised shares of Fabrinet from an “equal weight” rating to an “overweight” rating in a report on Wednesday, August 19th. Weiss Ratings lowered Fabrinet from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, August 12th. Barclays increased their price target on Fabrinet from $702.00 to $739.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 18th. JPMorgan Chase & Co. raised their price target on Fabrinet from $680.00 to $695.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Finally, Zacks Research lowered Fabrinet from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 15th. Six investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Fabrinet currently has a consensus rating of “Moderate Buy” and a consensus price target of $649.50.

Fabrinet Stock Performance

NYSE FN opened at $431.36 on Wednesday. Fabrinet has a one year low of $309.91 and a one year high of $748.89. The company has a 50-day simple moving average of $508.26 and a 200-day simple moving average of $568.07. The firm has a market capitalization of $15.46 billion, a PE ratio of 33.05 and a beta of 1.23.

Institutional Investors Weigh In On Fabrinet

Large investors have recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Fabrinet in the 1st quarter worth approximately $203,000. Empowered Funds LLC acquired a new position in shares of Fabrinet during the first quarter valued at approximately $2,331,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Fabrinet by 4.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,444 shares of the technology company’s stock worth $15,691,000 after purchasing an additional 3,717 shares in the last quarter. M&T Bank Corp bought a new stake in Fabrinet during the second quarter worth approximately $214,000. Finally, EverSource Wealth Advisors LLC lifted its position in Fabrinet by 574.7% in the second quarter. EverSource Wealth Advisors LLC now owns 533 shares of the technology company’s stock worth $157,000 after purchasing an additional 454 shares during the period. Institutional investors and hedge funds own 97.38% of the company’s stock.

Fabrinet Company Profile

Fabrinet is a global provider of advanced optical packaging and precision optical, electro?mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high?precision fiber alignment, micro?assembly, testing and diagnostics, and integration of electro?optic subassemblies.

Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.